Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-10-14

FDA Approved: CHEMET — Supplemental Application (Recordati Rare Diseases, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for CHEMET (succimer) from Recordati Rare Diseases, Inc., likely updating labeling or expanding indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CHEMET (succimer)

Snippet

SUPPL AP for CHEMET (SUCCIMER)